SCHEMBL13311889

SCHEMBL13311889

CNC(=O)C(CCCCN)NC(=O)C(CCCNC(C)=N)NC(=O)C(CCCNC(C)=N)NC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 5/20 0.53
▸ PLG P00747 1/20 0.49
▸ PRSS1 P07477 1/20 0.49
▸ PRSS2 P07478 1/20 0.49
▸ PRSS3 P35030 1/20 0.49
▸ TPSAB1 Q15661 1/20 0.49
▸ FOLH1 Q04609 3/20 0.47
▸ CAPN1 P07384 2/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ ABL1 P00519 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ IDE P14735 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ RIN1 Q13671 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ CA12 O43570 4/20 0.44
▸ CA1 P00915 4/20 0.44
▸ CA2 P00918 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13311891 0.95 TDP1 (0.56) TDP1PLGPRSS1PRSS2PRSS3
SCHEMBL14524253 0.94 TDP1 (0.47) TDP1PLGPRSS1PRSS2PRSS3
SCHEMBL13311877 0.93 TDP1 (0.51) TDP1PRSS1PRSS2PRSS3TPSAB1
SCHEMBL13311899 0.91 TDP1 (0.58) TDP1FOLH1CAPN1MEN1ABL1
SCHEMBL14524258 0.91 TDP1 (0.58) TDP1FOLH1CAPN1MEN1ABL1
SCHEMBL14524259 0.90 TDP1 (0.55) TDP1FOLH1CAPN1MEN1ABL1
SCHEMBL13311902 0.90 TDP1 (0.55) TDP1FOLH1CAPN1MEN1ABL1
SCHEMBL14524252 0.89 TDP1 (0.50) TDP1PLGPRSS1PRSS2PRSS3
SCHEMBL14524254 0.87 TDP1 (0.46) TDP1PRSS1PRSS2PRSS3TPSAB1
SCHEMBL13311913 0.85 TDP1 (0.58) TDP1PLGPRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160210-A1 GUANIDINIUM DELIVERY CARRIERS NITTO DENKO CORPORATION (JP) 2010-06-24 — — US disclosed
US-20070078094-A1 Guanidinium delivery carriers NITTO DENKO CORPORATION (JP) 2007-04-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160210-A1 GUANIDINIUM DELIVERY CARRIERS SLC2A9, SLC29A2, SLC2A4 TDP1 1606/4885PLG 1854/4885PRSS1 3564/4885
US-20070078094-A1 Guanidinium delivery carriers SLC2A9, SLC29A2, SLC2A4 TDP1 1606/4885PLG 1854/4885PRSS1 3564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback